Cancelled by the investigator A clinical study for ''Huo-Shen'' particles in the treatment of novel coronavirus pneumonia (COVID-19)
Phase 1
Not yet recruiting
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000003048
- Lead Sponsor
- Shenzhen national medicine inheritance medical research institute co. LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) All patients were diagnosed with a new type of coronavirus pneumonia;
(2) Clear mind, cooperation and communication;
(3) Men and women aged 18 and 80 years;
(4) informed consent has been signed and is willing to be assessed.
Exclusion Criteria
(1) with severe liver or kidney failure or other serious underlying diseases;
(2) Pregnant and lactating women;
(3) Persons who are participating in other clinical trials.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method